Zhang Fengchun

[Expert Profile] Zhang Fengchun, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in rheumatology and immunology in China, working in the Department of Rheumatology, Peking Union Medical College Hospital. He has long been dedicated to the clinical diagnosis, treatment, and scientific research of systemic sclerosis, dermatomyositis, polymyositis, and various difficult connective tissue diseases, and is a representative scholar in the fields of scleroderma and inflammatory myopathy in China.

[Education & Career] Professor Zhang Fengchun graduated from Peking Union Medical College, completed systematic clinical training in the Department of Rheumatology at Peking Union Medical College Hospital, and further studied at famous international rheumatology centers. He has long served as Director of the Rheumatology Department at PUMCH, holding important academic positions including Chair of the Rheumatology Branch of the Chinese Medical Association. He has presided over major projects including the National Natural Science Foundation of China and the National Key R&D Program, and is a highly respected senior discipline figure in the field of rheumatology in China.

[Areas of Expertise] Professor Zhang specializes in the diagnosis and treatment of various connective tissue diseases including systemic sclerosis (scleroderma), dermatomyositis, polymyositis, and mixed connective tissue disease. He has extensive experience in comprehensive management of systemic sclerosis complications such as interstitial lung disease, Raynaud's phenomenon, and dysphagia. He is proficient in individualized application of immunosuppressive therapy and biologics, and excels at managing complex situations such as inflammatory myopathy complicated with interstitial lung disease or malignancy, helping numerous scleroderma and myopathy patients control their conditions, protect important organs, and improve their quality of life.

[Academic Achievements & Industry Contributions] Professor Zhang has led the establishment of Chinese systemic sclerosis and inflammatory myopathy clinical cohorts, systematically studying the clinical features, organ involvement patterns, and prognostic factors of Chinese patient populations, with findings published in authoritative domestic and international journals. He has led the development of Chinese diagnosis and treatment guidelines and expert consensus statements for systemic sclerosis, dermatomyositis, and related conditions, actively promoted the construction of rare rheumatology diagnosis centers, and organized nationwide rheumatology specialist physician training, training a large number of rheumatology professionals and making outstanding contributions to the development and standardization of rheumatology in China.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Zhang has treated tens of thousands of patients with difficult rheumatic diseases such as scleroderma and dermatomyositis, with patient coverage extending nationwide. He is gentle, patient, and meticulous with patients, having provided clear diagnoses and developed standardized treatment plans for numerous connective tissue disease patients who were previously misdiagnosed over long periods. He has been repeatedly recognized as an outstanding physician at PUMCH and as a National Outstanding Science and Technology Worker. His rigorous academic style and benevolent medical ethics are deeply admired by patients and younger colleagues alike, and he is a renowned master of rheumatology across the country.

[Honors & Reputation] Professor Zhang Fengchun has long held academic positions including Chair of the Rheumatology Branch of the Chinese Medical Association and President of the Rheumatology Physicians Branch of the Chinese Medical Doctor Association. He has presided over national-level projects including key grants from the National Natural Science Foundation of China, and is a senior authority in the field of rheumatology and immunology in China. He has profound expertise in clinical and basic research on difficult rheumatic diseases including systemic sclerosis, dermatomyositis, and polymyositis. He has led research on standardized autoantibody testing and early diagnosis of rheumatic diseases, participated in the development of multiple rheumatology diagnosis and treatment guidelines and expert consensus statements, and edited multiple rheumatology monographs. He has helped numerous rheumatic disease patients who were long misdiagnosed or missed receive clear diagnoses and standardized treatment, trained a large number of rheumatology professionals, and is deeply trusted by patients and respected by peers alike.